Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy

Transplant Proc. 2002 Feb;34(1):73-4. doi: 10.1016/s0041-1345(01)02671-9.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Antibodies, Viral / therapeutic use*
  • Antilymphocyte Serum / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Cytomegalovirus / immunology*
  • Cytomegalovirus Infections / prevention & control*
  • Female
  • Ganciclovir / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / physiology
  • Male
  • Middle Aged
  • Retrospective Studies

Substances

  • Antibodies, Viral
  • Antilymphocyte Serum
  • Antiviral Agents
  • Immunosuppressive Agents
  • Ganciclovir